Amit Munshi - 20 Mar 2023 Form 3 Insider Report for Zura Bio Ltd (ZURA)

Role
Director
Signature
/s/ Kimberly Ann Davis, Attorney-in-Fact
Issuer symbol
ZURA
Transactions as of
20 Mar 2023
Net transactions value
$0
Form type
3
Filing time
21 Mar 2023, 19:36:00 UTC
Previous filing
15 Jun 2022
Next filing
02 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ZURA Class A Ordinary Shares 499,993 20 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ZURA Employee Share Option (Right to Buy) 20 Mar 2023 Class A Ordinary Shares 306,373 $8.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted Restricted Stock Units on March 18, 2023, which shall vest in four equal, annual installments, beginning on March 18, 2024, subject to the Reporting Person's continuous employment with the Issuer.
F2 The Reporting Person was granted on March 20, 2023 the option to purchase Issuer Class A Ordinary Shares at an exercise price per ordinary share equal to the fair market value of a Class A Ordinary Share at the date of grant, which will become exercisable if the volume weighted average price of the Issuer's Class A Ordinary Shares over twenty trading days is over $30 per Class A Ordinary Share at any time prior to March 20, 2028, subject to the Reporting Person remaining as Non-Executive Chairman of the Board of Directors of the Issuer.

Remarks:

Exhibit 24 - Power of Attorney